Consult this session for insights on customizing PCI strategies for high-bleeding-risk patients, and selecting Drug-Eluting Stents (#DES) in complex #PCI. Additionally, examine the outcomes of the Ultimaster DES in high-bleeding-risk trials, particularly in the context of short Dual Antiplatelet Therapy (#DAPT).
Sponsored by Terumo
More videos on: www.pcronline....